As of the end of 2023, Andres holds options totaling 65,000 shares in IDEAYA Biosciences, including 22,500 options granted in June 2023 due to his promotion. His holdings give him a substantial stake in the company's future. His options were...

As of the end of 2023, Andres holds options totaling 65,000 shares in IDEAYA Biosciences, including 22,500 options granted in June 2023 due to his promotion. His holdings give him a substantial stake in the company's future. His options were awarded at exercise prices reflecting the market value at the time, with future vesting tied to his continued service. Despite not realizing gains yet from stock options, their potential value indicates his commitment to the company's growth. The stock market is volatile, of course, but as the company progresses through key clinical trials, the value of his holdings could change significantly. Historically, earlier in his career, his wealth was also concentrated in IDEAYA stock, but current trends show diversification taking place as he builds a robust financial portfolio.